Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Effect of a vitamin and mineral supplementation on glycemic status: Results from a community-based program.

Kimball SM, Emery JCH, Lewanczuk RZ.

J Clin Transl Endocrinol. 2017 Nov 7;10:28-35. doi: 10.1016/j.jcte.2017.11.002. eCollection 2017 Dec.

2.

Development and implementation of an online clinical pathway for adult chronic kidney disease in primary care: a mixed methods study.

Donald M, McBrien K, Jackson W, Manns BJ, Tonelli M, King-Shier K, Jindal K, Lewanczuk RZ, Scott-Douglas N, Braun T, Straus SE, Naugler C, Elliott MJ, Jun M, Hemmelgarn BR.

BMC Med Inform Decis Mak. 2016 Aug 17;16:109. doi: 10.1186/s12911-016-0350-z.

3.

Pharmacists on primary care teams: Effect on antihypertensive medication management in patients with type 2 diabetes.

Omran D, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Guirguis LM, Makowsky M, Simpson SH.

J Am Pharm Assoc (2003). 2015 May-Jun;55(3):265-8. doi: 10.1331/JAPhA.2015.14225.

PMID:
25909463
4.

Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.

Simpson SH, Lier DA, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA.

Diabet Med. 2015 Jul;32(7):899-906. doi: 10.1111/dme.12692. Epub 2015 Feb 2.

PMID:
25594919
5.

Anthropometric and dietary predictors of insulin sensitivity in 10- to 14-year-old boys and girls.

Forbes LE, Downs SM, Fraser SN, Majumdar SR, Ball GD, Plotnikoff RC, Wozny PD, Torrance BD, McCargar LJ, Lewanczuk RZ, McGavock JM.

Appl Physiol Nutr Metab. 2013 Mar;38(3):320-5. doi: 10.1139/apnm-2012-0232. Epub 2012 Oct 12.

PMID:
23537025
6.

Treating patients and treating populations: the value of population data in controlling hypertension.

Lewanczuk RZ.

Can J Cardiol. 2013 May;29(5):524-5. doi: 10.1016/j.cjca.2013.02.002. Epub 2013 Mar 21. No abstract available.

PMID:
23523106
7.

Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.

Gilani F, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, Simpson SH.

Ann Pharmacother. 2013 Jan;47(1):43-8. doi: 10.1345/aph.1R552. Epub 2013 Jan 16.

PMID:
23324512
8.

Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.

Ladhani NN, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, Simpson SH.

Diabet Med. 2012 Nov;29(11):1433-9. doi: 10.1111/j.1464-5491.2012.03673.x.

PMID:
22486226
9.

Metformin and exercise in type 2 diabetes: examining treatment modality interactions.

Boulé NG, Robert C, Bell GJ, Johnson ST, Bell RC, Lewanczuk RZ, Gabr RQ, Brocks DR.

Diabetes Care. 2011 Jul;34(7):1469-74. doi: 10.2337/dc10-2207. Epub 2011 May 20.

10.

Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study.

Padwal RS, Damjanovic S, Schulze KM, Lewanczuk RZ, Lau DC, Sharma AM.

J Obes. 2011;2011:686521. doi: 10.1155/2011/686521. Epub 2010 Nov 21.

11.

Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.

Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA.

Diabetes Care. 2011 Jan;34(1):20-6. doi: 10.2337/dc10-1294. Epub 2010 Oct 7.

12.

2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations.

Campbell NR, Kaczorowski J, Lewanczuk RZ, Feldman R, Poirier L, Kwong MM, Lebel M, McAlister FA, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2010 May;26(5):236-40. Review.

13.

A novel, non-invasive 13C-glucose breath test to estimate insulin resistance in obese prepubertal children.

Jetha MM, Nzekwu U, Lewanczuk RZ, Ball GD.

J Pediatr Endocrinol Metab. 2009 Nov;22(11):1051-9.

PMID:
20101891
14.

DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.

Tobe SW, Wentworth J, Ironstand L, Hartman S, Hoppe J, Whiting J, Kennedy J, McAllister C, Kiss A, Perkins N, Vincent L, Pylypchuk G, Lewanczuk RZ.

BMC Endocr Disord. 2009 May 9;9:13. doi: 10.1186/1472-6823-9-13.

15.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

16.

2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update.

Campbell NR, Khan NA, Hill MD, Tremblay G, Lebel M, Kaczorowski J, McAlister FA, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):271-7. Review.

17.

Cardiorespiratory fitness and the risk of overweight in youth: the Healthy Hearts Longitudinal Study of Cardiometabolic Health.

McGavock JM, Torrance BD, McGuire KA, Wozny PD, Lewanczuk RZ.

Obesity (Silver Spring). 2009 Sep;17(9):1802-7. doi: 10.1038/oby.2009.59. Epub 2009 Mar 12.

18.

Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab.

Ling S, Lewanczuk RZ, Russell AS, Ihejirika B, Jamali F.

J Clin Pharmacol. 2009 Mar;49(3):301-11. doi: 10.1177/0091270008328099. Epub 2009 Jan 23.

PMID:
19168802
19.

Tackling the burden of hypertension in Canada: encouraging collaborative care.

Thompson A, Campbell NR, Cloutier L, Costello JA, Dawes M, Hickey J, Kaczorowski J, Lewanczuk RZ, Semchuk W, Tsuyuki RT; Canadian Hypertension Education Program Implementation Task Force.

Can Fam Physician. 2008 Dec;54(12):1659-62, 1664-7. Review. English, French. No abstract available.

20.

Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP).

Jones C, Simpson SH, Mitchell D, Haggarty S, Campbell N, Then K, Lewanczuk RZ, Sebaldt RJ, Farrell B, Dolovitch L, Kaczorowski J, Chambers LW.

Can J Cardiol. 2008 Jul;24(7):561-7.

21.
22.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ; Canadian Hypertension Education Program.

Can J Cardiol. 2008 Jun;24(6):465-75. Review.

23.

Acute effect of metformin on exercise capacity in active males.

Johnson ST, Robert C, Bell GJ, Bell RC, Lewanczuk RZ, Boulé NG.

Diabetes Obes Metab. 2008 Sep;10(9):747-54. Epub 2007 Oct 26.

PMID:
17970761
24.

The relationship between weight gain and blood pressure in children and adolescents.

McGavock JM, Torrance B, McGuire KA, Wozny P, Lewanczuk RZ.

Am J Hypertens. 2007 Oct;20(10):1038-44.

PMID:
17903685
25.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2007 May 15;23(7):539-50.

26.

The natural history of LDL control in type 2 diabetes: a prospective study of adherence to lipid guidelines.

Rucker D, Johnson JA, Lee TK, Eurich DT, Lewanczuk RZ, Simpson SH, Toth EL, Majumdar SR.

Diabetes Care. 2006 Nov;29(11):2506-8. No abstract available.

PMID:
17065693
27.

Drug-disease interactions: losartan effect is not downregulated by rheumatoid arthritis.

Daneshtalab N, Lewanczuk RZ, Russell AS, Jamali F.

J Clin Pharmacol. 2006 Nov;46(11):1344-55.

PMID:
17050800
28.

Impaired arterial compliance and aerobic endurance in kidney transplant recipients.

Riess KJ, Gourishankar S, Oreopoulos A, Jones LW, McGavock JM, Lewanczuk RZ, Haykowsky MJ.

Transplantation. 2006 Oct 15;82(7):920-3.

PMID:
17038907
29.

Sedentary lifestyle and antecedents of cardiovascular disease in young adults.

McGavock JM, Anderson TJ, Lewanczuk RZ.

Am J Hypertens. 2006 Jul;19(7):701-7.

PMID:
16814124
30.

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Campbell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Larochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Tobe S, Touyz RM; Canadian Hypertension Education Program.

Can J Cardiol. 2006 May 15;22(7):583-93.

31.

Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension.

Khan NA, Hamet P, Lewanczuk RZ; Canadian Hypertension Education Program.

CMAJ. 2005 Oct 11;173(8):865-7. No abstract available.

32.

Arterial compliance in young children: the role of aerobic fitness.

Reed KE, Warburton DE, Lewanczuk RZ, Haykowsky MJ, Scott JM, Whitney CL, McGavock JM, McKay HA.

Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):492-7.

PMID:
16210937
33.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program.

Can J Cardiol. 2005 Jun;21(8):657-72.

PMID:
16003449
34.

Generalizability and persistence of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes.

Johnson JA, Eurich DT, Toth EL, Lewanczuk RZ, Lee TK, Majumdar SR.

Diabetes Care. 2005 Apr;28(4):783-8.

PMID:
15793173
35.

Trends in bariatric surgery in Canada, 1993-2003.

Padwal RS, Lewanczuk RZ.

CMAJ. 2005 Mar 15;172(6):735. No abstract available. Erratum in: CMAJ. 2005 Apr 26;172(9):1164.

36.

Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.

Leiter LA, Lewanczuk RZ.

Am J Hypertens. 2005 Jan;18(1):121-8. Review.

PMID:
15691626
37.

Treatment gaps for hypertension management in rural Canadian patients with type 2 diabetes mellitus.

Supina AL, Guirguis LM, Majumdar SR, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA.

Clin Ther. 2004 Apr;26(4):598-606.

PMID:
15189757
38.

Improvements in patient-reported outcomes associated with an intervention to enhance quality of care for rural patients with type 2 diabetes: results of a controlled trial.

Maddigan SL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA.

Diabetes Care. 2004 Jun;27(6):1306-12.

PMID:
15161780
39.

Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada.

Klinke JA, Johnson JA, Guirguis LM, Toth EL, Lee TK, Lewanczuk RZ, Majumdar SR.

Clin Ther. 2004 Mar;26(3):439-46.

PMID:
15110137
40.

Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.

Daneshtalab N, Lewanczuk RZ, Russell A, Jamali F.

J Clin Pharmacol. 2004 Mar;44(3):245-52.

PMID:
14973301
41.
42.

Low cardiorespiratory fitness is associated with elevated C-reactive protein levels in women with type 2 diabetes.

McGavock JM, Mandic S, Vonder Muhll I, Lewanczuk RZ, Quinney HA, Taylor DA, Welsh RC, Haykowsky M.

Diabetes Care. 2004 Feb;27(2):320-5.

PMID:
14747207
43.

Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes.

Majumdar SR, Guirguis LM, Toth EL, Lewanczuk RZ, Lee TK, Johnson JA.

Diabetes Care. 2003 Nov;26(11):3061-6.

PMID:
14578240
44.

Generation, characterization, and use of monoclonal antibodies against parathyroid hypertensive factor.

Krylova S, Labedz T, Lewanczuk RZ, Benishin CG.

Clin Chem. 2003 Jul;49(7):1204-6. No abstract available.

45.

Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement.

Toth EL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Johnson JA.

Pharmacotherapy. 2003 May;23(5):659-65.

PMID:
12741441
46.

High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method.

Daneshtalab N, Lewanczuk RZ, Jamali F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 25;766(2):345-9.

PMID:
11824822
47.

Effect of testosterone on intracellular Ca++ in vascular smooth muscle cells.

Barbagallo M, Dominguez LJ, Licata G, Ruggero R, Lewanczuk RZ, Pang PK, Resnick LM.

Am J Hypertens. 2001 Dec;14(12):1273-5. No abstract available.

PMID:
11775138
48.

Vascular compliance is reduced in the early stages of type 1 diabetes.

Romney JS, Lewanczuk RZ.

Diabetes Care. 2001 Dec;24(12):2102-6.

PMID:
11723091
49.

Hyperplacentosis: a novel cause of hyperthyroidism.

Ginsberg J, Lewanczuk RZ, Honore LH.

Thyroid. 2001 Apr;11(4):393-6.

PMID:
11349840
50.

Quantitative determination of parathyroid hypertensive factor by enzyme-linked immunosorbent assay.

Krylova SM, Pang PK, Shan J, Lewanczuk RZ, Benishin CG.

Am J Hypertens. 2000 Nov;13(11):1173-9.

PMID:
11078177

Supplemental Content

Loading ...
Support Center